BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26619923)

  • 1. Characteristics and Outcomes of HEDIS-Defined Asthma Patients with COPD Diagnostic Coding.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2016; 4(2):273-83.e5. PubMed ID: 26619923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
    J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study.
    Zeiger RS; Schatz M; Dalal AA; Chen W; Sadikova E; Suruki RY; Kawatkar AA; Qian L
    J Allergy Clin Immunol Pract; 2017; 5(1):144-153.e8. PubMed ID: 27665383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
    Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
    J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
    Yun JH; Lamb A; Chase R; Singh D; Parker MM; Saferali A; Vestbo J; Tal-Singer R; Castaldi PJ; Silverman EK; Hersh CP;
    J Allergy Clin Immunol; 2018 Jun; 141(6):2037-2047.e10. PubMed ID: 29709670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.
    Vogelmeier CF; Kostikas K; Fang J; Tian H; Jones B; Morgan CL; Fogel R; Gutzwiller FS; Cao H
    Respir Res; 2019 Aug; 20(1):178. PubMed ID: 31391053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts.
    Müllerová H; Hahn B; Simard EP; Mu G; Hatipoğlu U
    Int J Chron Obstruct Pulmon Dis; 2019; 14():683-692. PubMed ID: 30962682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of disease associated with a COPD eosinophilic phenotype.
    Ortega H; Llanos JP; Lafeuille MH; Germain G; Duh MS; Bell CF; Sama SR; Hahn B
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2425-2433. PubMed ID: 30147308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
    COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada.
    Poder TG; Carrier N; Bélanger M; Couillard S; Courteau J; Larivée P; Vanasse A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3065-3076. PubMed ID: 30349220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood eosinophil count variability in chronic obstructive pulmonary disease and severe asthma.
    Abe Y; Suzuki M; Kimura H; Shimizu K; Takei N; Oguma A; Matsumoto-Sasaki M; Goudarzi H; Makita H; Nishimura M; Konno S
    Allergol Int; 2023 Jul; 72(3):402-410. PubMed ID: 36586746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
    Price DB; Rigazio A; Campbell JD; Bleecker ER; Corrigan CJ; Thomas M; Wenzel SE; Wilson AM; Small MB; Gopalan G; Ashton VL; Burden A; Hillyer EV; Kerkhof M; Pavord ID
    Lancet Respir Med; 2015 Nov; 3(11):849-58. PubMed ID: 26493938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.
    Hirai K; Shirai T; Suzuki M; Akamatsu T; Suzuki T; Hayashi I; Yamamoto A; Akita T; Morita S; Asada K; Tsuji D; Inoue K; Itoh K
    Clin Exp Allergy; 2017 Nov; 47(11):1374-1382. PubMed ID: 28658564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of peripheral blood eosinophil markers to predict severity of asthma.
    Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
    BMC Pulm Med; 2016 Jul; 16(1):109. PubMed ID: 27473851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.
    Pascoe S; Locantore N; Dransfield MT; Barnes NC; Pavord ID
    Lancet Respir Med; 2015 Jun; 3(6):435-42. PubMed ID: 25878028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.
    Kostikas K; Brindicci C; Patalano F
    Curr Drug Targets; 2018; 19(16):1882-1896. PubMed ID: 29437007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils.
    Marks-Konczalik J; Costa M; Robertson J; McKie E; Yang S; Pascoe S
    Respir Med; 2015 Jul; 109(7):860-9. PubMed ID: 26033641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma.
    George L; Taylor AR; Esteve-Codina A; Soler Artigas M; Thun GA; Bates S; Pavlidis S; Wagers S; Boland A; Prasse A; Boschetto P; Parr DG; Nowinski A; Barta I; Hohlfeld J; Greulich T; van den Berge M; Hiemstra PS; Timens W; Hinks T; Wenzel S; Siddiqui S; Richardson M; Venge P; Heath S; Gut I; Tobin MD; Edwards L; Riley JH; Djukanovic R; Auffray C; De-Meulder B; Erik-Dahlen S; Adcock IM; Chung KF; Ziegler-Heitbrock L; Sterk PJ; Singh D; Brightling CE;
    Allergy; 2020 Feb; 75(2):370-380. PubMed ID: 31506971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.